{"gene":"CHRNB4","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2011,"finding":"Rare missense variants in CHRNB4 (T375I and T91I) increase cellular response to nicotine when co-expressed with the α3 subunit in vitro, and carrier status of rare missense variants at conserved residues in CHRNB4 is associated with reduced risk of nicotine dependence and fewer cigarettes per day.","method":"In vitro functional assay (co-expression with α3 subunit), pooled sequencing, carrier-status association analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro functional assay with mutagenesis, single study","pmids":["22042774"],"is_preprint":false},{"year":2014,"finding":"Non-synonymous CHRNB4 variants modulate receptor sensitivity; when co-expressed with α3 or α4 subunits in HEK cells, variants alter acetylcholine/nicotine concentration-response curves (EC50 and maximal response), and functional weighting by acetylcholine EC50 or low-nicotine response significantly improves gene-based association with smoking behavior, suggesting increased sensitivity to low nicotine concentrations is protective against nicotine dependence.","method":"Voltage-clamp electrophysiology, qRT-PCR, western blot, cell-surface ELISA, gene-based association test with functional weighting","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with electrophysiology, expression assays, and genetic association; multiple orthogonal methods in single study","pmids":["24804708"],"is_preprint":false},{"year":2010,"finding":"A CA box regulatory element (5'-CCACCCCT-3') in the CHRNB4 promoter is critical for β4 subunit gene expression in vivo; mutation of this element abolishes reporter gene expression at embryonic day 18.5 and drastically reduces it at postnatal day 30 in transgenic mice, and CA box mutation decreases interaction of transcription factor Sp1 with the β4 promoter.","method":"Transgenic mouse reporter assay, mutagenesis of promoter element, in vivo imaging of reporter expression, Sp1 binding assay","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 1 — in vivo mutagenesis with reporter assay and transcription factor binding validation; multiple orthogonal methods","pmids":["20696214"],"is_preprint":false},{"year":2012,"finding":"CHRNB4 promoter hypomethylation in lung tumors leads to overexpression of CHRNB4 transcript; treatment of H1299 cells with decitabine reduces methylation and elevates CHRNB4 mRNA, demonstrating epigenetic regulation. CHRNB4 knockdown in A549 and H1299 cells reduces proliferation and colony formation, indicating a functional role in tumorigenic potential.","method":"Bisulfite sequencing/methylation analysis, decitabine treatment, siRNA knockdown, proliferation and colony-formation assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (methylation, pharmacologic demethylation, KD with two phenotypic readouts) in a single study","pmids":["22945651"],"is_preprint":false},{"year":2001,"finding":"The human CHRNB4 gene (encoding the nAChR β4 subunit) was fully characterized including genomic structure and chromosomal mapping; mouse studies showed that loss of β4 subunit impairs bladder contraction in response to nicotine, and combined loss of β2 and β4 (but not single knockouts) produces severe autonomic phenotypes including megacystis and pupil dilation, establishing CHRNB4 as essential for autonomic ganglionic nicotinic receptor function.","method":"Gene characterization, mouse knockout phenotyping (bladder contraction assay, anatomical assessment), mutation analysis","journal":"Journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function mouse models with defined physiological readout; replicated with multiple genotypes","pmids":["11450844"],"is_preprint":false},{"year":2017,"finding":"The Chrnb4-EGFP transgenic mouse line labels a sub-population of early retinal progenitors that becomes progressively restricted to mature cone photoreceptors during retina development, and native CHRNB4 protein is confirmed in EGFP-positive cone cells with a similar expression pattern in human retina.","method":"Transgenic reporter mouse characterization, immunohistochemistry, sub-retinal transplantation, live imaging","journal":"Molecular therapy : the journal of the American Society of Gene Therapy","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with immunohistochemistry confirming native protein, tied to functional transplantation experiments","pmids":["28143742"],"is_preprint":false},{"year":2019,"finding":"Conditional deletion of Dicer1 in Chrnb4-expressing cone photoreceptors (using Chrnb4-Cre) causes progressive cone degeneration with absent/short outer segments by 3 weeks of age, 50% cone loss by 4 months, and impaired photopic vision by ERG, demonstrating that CHRNB4-expressing cones require Dicer1 (and thus miRNA biogenesis) for survival and homeostasis.","method":"Conditional knockout mouse (Chrnb4-Cre; Dicer1 flox/flox), electroretinography, RNAseq, histology","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with functional (ERG) and molecular (RNAseq) readouts; validates Chrnb4-Cre as cone-specific driver","pmids":["30783126"],"is_preprint":false}],"current_model":"CHRNB4 encodes the nicotinic acetylcholine receptor β4 subunit that forms heteropentameric nAChRs with α3 (and other) subunits; its expression is driven by an Sp1-dependent CA-box promoter element and is epigenetically regulated by promoter DNA methylation; rare missense variants alter receptor sensitivity to nicotine and acetylcholine, modulating nicotine dependence risk; in the autonomic nervous system β4-containing receptors are required for ganglionic cholinergic transmission (bladder contraction), and in the retina CHRNB4-expressing cone photoreceptors require Dicer1-dependent miRNA biogenesis for survival, while CHRNB4 overexpression (via promoter hypomethylation) promotes lung cancer cell proliferation."},"narrative":{"teleology":[{"year":2001,"claim":"The genomic structure of CHRNB4 was defined and knockout mouse studies established that the β4 subunit is required for nicotinic receptor-mediated autonomic ganglionic function, resolving whether β4 is redundant with other β subunits in vivo.","evidence":"Mouse knockout phenotyping (β4 single and β2/β4 double KO) with bladder contraction assays and anatomical assessment","pmids":["11450844"],"confidence":"Medium","gaps":["Autonomic phenotype of β4 single KO was mild; severe phenotypes required combined β2/β4 loss, leaving the degree of β4 vs β2 redundancy unresolved","No electrophysiological recordings from autonomic ganglia to define channel-level mechanism"]},{"year":2010,"claim":"Identification of the Sp1-dependent CA-box promoter element as essential for CHRNB4 transcription answered how tissue-appropriate expression of the β4 subunit gene is driven.","evidence":"Transgenic mouse reporter assay with CA-box mutagenesis and Sp1 binding analysis","pmids":["20696214"],"confidence":"High","gaps":["Other transcription factors or enhancers contributing to tissue-specific expression were not identified","The link between Sp1 binding and chromatin context was not addressed"]},{"year":2011,"claim":"Functional characterization of rare CHRNB4 missense variants demonstrated that specific amino acid changes increase receptor response to nicotine, providing a mechanistic basis for the protective association of these variants against nicotine dependence.","evidence":"In vitro co-expression of mutant β4 with α3 subunit, electrophysiology, and carrier-status genetic association","pmids":["22042774"],"confidence":"Medium","gaps":["Only two variants characterized in detail; broader variant landscape not functionally mapped","In vivo confirmation in animal models lacking"]},{"year":2012,"claim":"Demonstration that CHRNB4 is epigenetically silenced by promoter methylation and that its overexpression through hypomethylation contributes to lung cancer cell proliferation established a non-neuronal oncogenic role for this receptor subunit.","evidence":"Bisulfite sequencing, decitabine demethylation, siRNA knockdown with proliferation and colony-formation assays in A549/H1299 cells","pmids":["22945651"],"confidence":"High","gaps":["Downstream signaling pathway linking β4 overexpression to proliferation was not defined","Whether the proliferative effect requires assembly into functional pentameric receptors is unknown"]},{"year":2014,"claim":"Systematic electrophysiological profiling of multiple CHRNB4 non-synonymous variants with α3 and α4 co-expression quantified how altered agonist EC50 and maximal response mediate genetic protection against smoking, refining the gain-of-function model for nicotine dependence risk.","evidence":"Voltage-clamp electrophysiology, cell-surface ELISA, qRT-PCR, gene-based association with functional weighting in HEK cells","pmids":["24804708"],"confidence":"High","gaps":["Structural basis for variant-induced changes in agonist sensitivity not determined","Functional weighting approach not validated in independent cohorts"]},{"year":2017,"claim":"Discovery that CHRNB4 marks a cone photoreceptor lineage in the retina expanded the known expression domain of β4 beyond the nervous system and provided a cone-specific genetic tool.","evidence":"Chrnb4-EGFP transgenic reporter mouse, immunohistochemistry confirming native β4 protein in cones, validated in human retina","pmids":["28143742"],"confidence":"Medium","gaps":["Functional role of β4 protein in cone photoreceptor physiology was not addressed","Whether β4 forms functional nAChR channels in cones is unknown"]},{"year":2019,"claim":"Conditional Dicer1 deletion in Chrnb4-Cre-expressing cones caused progressive cone degeneration and visual impairment, demonstrating that miRNA biogenesis is required for the survival of CHRNB4-expressing cone photoreceptors.","evidence":"Conditional knockout mouse (Chrnb4-Cre; Dicer1 flox/flox), ERG, RNAseq, histology","pmids":["30783126"],"confidence":"Medium","gaps":["Specific miRNAs responsible for cone survival were not identified","Whether β4 itself has a functional (non-Cre-driver) role in cone homeostasis remains untested"]},{"year":null,"claim":"The downstream signaling pathways through which β4-containing nAChRs promote lung cancer cell proliferation, the structural basis of variant-altered agonist sensitivity, and whether β4 forms functional ion channels in cone photoreceptors remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural data for α3β4 pentamer with disease-associated variants","Mechanism linking β4 overexpression to oncogenic signaling is undefined","Functional significance of β4 protein in retinal cones is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,4]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3]}],"complexes":["α3β4 nicotinic acetylcholine receptor"],"partners":["CHRNA3","CHRNA4","SP1"],"other_free_text":[]},"mechanistic_narrative":"CHRNB4 encodes the β4 subunit of nicotinic acetylcholine receptors (nAChRs), which assembles with α3 and other α subunits into heteropentameric ligand-gated ion channels essential for autonomic ganglionic cholinergic transmission and modulation of nicotine sensitivity [PMID:11450844, PMID:24804708]. Transcription of CHRNB4 requires an Sp1-dependent CA-box promoter element, and its expression is regulated by promoter DNA methylation; hypomethylation-driven overexpression in lung cancer cells promotes proliferation and colony formation [PMID:20696214, PMID:22945651]. Rare missense variants in CHRNB4 alter agonist sensitivity of α3β4 receptors—increasing response to low nicotine concentrations—and are associated with reduced nicotine dependence risk [PMID:22042774, PMID:24804708]. Beyond the nervous system, CHRNB4 marks a cone photoreceptor lineage in the retina, where Dicer1-dependent miRNA biogenesis in CHRNB4-expressing cones is required for their survival and photopic visual function [PMID:28143742, PMID:30783126]."},"prefetch_data":{"uniprot":{"accession":"P30926","full_name":"Neuronal acetylcholine receptor subunit beta-4","aliases":[],"length_aa":498,"mass_kda":56.4,"function":"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (PubMed:20881005, PubMed:31488329, PubMed:8663494, PubMed:8906617, PubMed:9203638). CHRNB4 forms heteropentameric neuronal acetylcholine receptors with CHRNA2, CHRNA3 and CHRNA4, as well as CHRNA5 and CHRNB3 as accesory subunits (PubMed:11118490, PubMed:20881005, PubMed:8663494). CHRNA3:CHRNB4 being predominant in neurons of the autonomic ganglia, it is known as ganglionic nicotinic receptor (PubMed:31488329). CHRNA3:CHRNB4 or CHRNA3:CHRNA5:CHRNB4 play also an important role in the habenulo-interpeduncular tract, modulating the mesolimbic dopamine system and affecting reward circuits and addiction (By similarity). Hypothalamic CHRNA3:CHRNB4 nAChR activation by nicotine leads to activation of POMC neurons and a decrease in food intake (By similarity)","subcellular_location":"Synaptic cell membrane; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P30926/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CHRNB4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CHRNB4","total_profiled":1310},"omim":[{"mim_id":"613493","title":"IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3","url":"https://www.omim.org/entry/613493"},{"mim_id":"612052","title":"SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3","url":"https://www.omim.org/entry/612052"},{"mim_id":"610509","title":"RIC3 ACETYLCHOLINE RECEPTOR CHAPERONE; RIC3","url":"https://www.omim.org/entry/610509"},{"mim_id":"603204","title":"EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2","url":"https://www.omim.org/entry/603204"},{"mim_id":"600513","title":"EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1","url":"https://www.omim.org/entry/600513"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"adrenal gland","ntpm":2.3},{"tissue":"lymphoid tissue","ntpm":2.7},{"tissue":"retina","ntpm":2.6},{"tissue":"testis","ntpm":5.6}],"url":"https://www.proteinatlas.org/search/CHRNB4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P30926","domains":[{"cath_id":"2.70.170.10","chopping":"51-231","consensus_level":"high","plddt":93.5342,"start":51,"end":231},{"cath_id":"1.20.58,1.20.58","chopping":"236-348_465-485","consensus_level":"high","plddt":89.1965,"start":236,"end":485}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30926","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30926-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30926-F1-predicted_aligned_error_v6.png","plddt_mean":81.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CHRNB4","jax_strain_url":"https://www.jax.org/strain/search?query=CHRNB4"},"sequence":{"accession":"P30926","fasta_url":"https://rest.uniprot.org/uniprotkb/P30926.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30926/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30926"}},"corpus_meta":[{"pmid":"19706762","id":"PMC_19706762","title":"The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19706762","citation_count":218,"is_preprint":false},{"pmid":"21747048","id":"PMC_21747048","title":"Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.","date":"2011","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/21747048","citation_count":152,"is_preprint":false},{"pmid":"19429911","id":"PMC_19429911","title":"A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19429911","citation_count":121,"is_preprint":false},{"pmid":"22648373","id":"PMC_22648373","title":"Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.","date":"2012","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22648373","citation_count":115,"is_preprint":false},{"pmid":"21593077","id":"PMC_21593077","title":"Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index.","date":"2011","source":"International journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/21593077","citation_count":94,"is_preprint":false},{"pmid":"19628476","id":"PMC_19628476","title":"Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19628476","citation_count":91,"is_preprint":false},{"pmid":"28143742","id":"PMC_28143742","title":"Cone Genesis Tracing by the Chrnb4-EGFP Mouse Line: Evidences of Cellular Material Fusion after Cone Precursor Transplantation.","date":"2017","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28143742","citation_count":64,"is_preprint":false},{"pmid":"21168125","id":"PMC_21168125","title":"TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood.","date":"2010","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21168125","citation_count":62,"is_preprint":false},{"pmid":"22956269","id":"PMC_22956269","title":"Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) interacts with maternal self-reported smoking status during pregnancy to influence birth weight.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22956269","citation_count":58,"is_preprint":false},{"pmid":"20886544","id":"PMC_20886544","title":"Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20886544","citation_count":52,"is_preprint":false},{"pmid":"19859904","id":"PMC_19859904","title":"Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19859904","citation_count":51,"is_preprint":false},{"pmid":"22241830","id":"PMC_22241830","title":"Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits.","date":"2012","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/22241830","citation_count":50,"is_preprint":false},{"pmid":"22042774","id":"PMC_22042774","title":"Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22042774","citation_count":47,"is_preprint":false},{"pmid":"22945651","id":"PMC_22945651","title":"Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22945651","citation_count":33,"is_preprint":false},{"pmid":"24186853","id":"PMC_24186853","title":"Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking.","date":"2013","source":"Genetic epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/24186853","citation_count":29,"is_preprint":false},{"pmid":"20631687","id":"PMC_20631687","title":"Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility.","date":"2010","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20631687","citation_count":25,"is_preprint":false},{"pmid":"27758088","id":"PMC_27758088","title":"The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.","date":"2016","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/27758088","citation_count":24,"is_preprint":false},{"pmid":"26689306","id":"PMC_26689306","title":"Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.","date":"2015","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26689306","citation_count":24,"is_preprint":false},{"pmid":"22438940","id":"PMC_22438940","title":"Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smoking.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22438940","citation_count":22,"is_preprint":false},{"pmid":"22042234","id":"PMC_22042234","title":"Externalizing behaviors are associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 gene cluster.","date":"2011","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22042234","citation_count":22,"is_preprint":false},{"pmid":"23875064","id":"PMC_23875064","title":"Scrutiny of the CHRNA5-CHRNA3-CHRNB4 smoking behavior locus reveals a novel association with alcohol use in a Finnish population based study.","date":"2013","source":"International journal of molecular epidemiology and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23875064","citation_count":22,"is_preprint":false},{"pmid":"11450844","id":"PMC_11450844","title":"Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4.","date":"2001","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11450844","citation_count":22,"is_preprint":false},{"pmid":"29666375","id":"PMC_29666375","title":"Association and cis-mQTL analysis of variants in CHRNA3-A5, CHRNA7, CHRNB2, and CHRNB4 in relation to nicotine dependence in a Chinese Han population.","date":"2018","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29666375","citation_count":18,"is_preprint":false},{"pmid":"23397474","id":"PMC_23397474","title":"Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population.","date":"2012","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23397474","citation_count":17,"is_preprint":false},{"pmid":"25214750","id":"PMC_25214750","title":"Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment.","date":"2013","source":"Journal of food and drug analysis","url":"https://pubmed.ncbi.nlm.nih.gov/25214750","citation_count":14,"is_preprint":false},{"pmid":"30783126","id":"PMC_30783126","title":"Conditional Dicer1 depletion using Chrnb4-Cre leads to cone cell death and impaired photopic vision.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30783126","citation_count":12,"is_preprint":false},{"pmid":"32879784","id":"PMC_32879784","title":"Validating Fluorescent Chrnb4.EGFP Mouse Models for the Study of Cone Photoreceptor Degeneration.","date":"2020","source":"Translational vision science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/32879784","citation_count":12,"is_preprint":false},{"pmid":"23729684","id":"PMC_23729684","title":"Smoking status, snus use, and variation at the CHRNA5-CHRNA3-CHRNB4 locus in relation to obesity: the GLACIER study.","date":"2013","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/23729684","citation_count":11,"is_preprint":false},{"pmid":"25891420","id":"PMC_25891420","title":"Exon sequencing identifies a novel CHRNA3-CHRNA5-CHRNB4 variant that increases the risk for chronic obstructive pulmonary disease.","date":"2015","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/25891420","citation_count":9,"is_preprint":false},{"pmid":"23029550","id":"PMC_23029550","title":"Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23029550","citation_count":9,"is_preprint":false},{"pmid":"29416783","id":"PMC_29416783","title":"Study on polymorphisms in CHRNA5/CHRNA3/CHRNB4 gene cluster and the associated with the risk of non-small cell lung cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29416783","citation_count":9,"is_preprint":false},{"pmid":"26942719","id":"PMC_26942719","title":"Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26942719","citation_count":8,"is_preprint":false},{"pmid":"20696214","id":"PMC_20696214","title":"A transcriptional regulatory element critical for CHRNB4 promoter activity in vivo.","date":"2010","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20696214","citation_count":7,"is_preprint":false},{"pmid":"24804708","id":"PMC_24804708","title":"Functional characterization improves associations between rare non-synonymous variants in CHRNB4 and smoking behavior.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24804708","citation_count":6,"is_preprint":false},{"pmid":"21228559","id":"PMC_21228559","title":"An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease.","date":"2011","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21228559","citation_count":5,"is_preprint":false},{"pmid":"30882151","id":"PMC_30882151","title":"Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.","date":"2020","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/30882151","citation_count":5,"is_preprint":false},{"pmid":"38862938","id":"PMC_38862938","title":"Investigating CHRNA5, CHRNA3, and CHRNB4 variants in the genetic landscape of substance use disorder in Jordan.","date":"2024","source":"BMC psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/38862938","citation_count":4,"is_preprint":false},{"pmid":"40534703","id":"PMC_40534703","title":"The impact of bilberry extract combined with docosahexaenoic acid on the expression of Chrnb4 gene in the sclera of myopic guinea pigs.","date":"2025","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40534703","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23169,"output_tokens":1879,"usd":0.048846},"stage2":{"model":"claude-opus-4-6","input_tokens":5172,"output_tokens":2037,"usd":0.115178},"total_usd":0.164024,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"Rare missense variants in CHRNB4 (T375I and T91I) increase cellular response to nicotine when co-expressed with the α3 subunit in vitro, and carrier status of rare missense variants at conserved residues in CHRNB4 is associated with reduced risk of nicotine dependence and fewer cigarettes per day.\",\n      \"method\": \"In vitro functional assay (co-expression with α3 subunit), pooled sequencing, carrier-status association analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay with mutagenesis, single study\",\n      \"pmids\": [\"22042774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Non-synonymous CHRNB4 variants modulate receptor sensitivity; when co-expressed with α3 or α4 subunits in HEK cells, variants alter acetylcholine/nicotine concentration-response curves (EC50 and maximal response), and functional weighting by acetylcholine EC50 or low-nicotine response significantly improves gene-based association with smoking behavior, suggesting increased sensitivity to low nicotine concentrations is protective against nicotine dependence.\",\n      \"method\": \"Voltage-clamp electrophysiology, qRT-PCR, western blot, cell-surface ELISA, gene-based association test with functional weighting\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with electrophysiology, expression assays, and genetic association; multiple orthogonal methods in single study\",\n      \"pmids\": [\"24804708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A CA box regulatory element (5'-CCACCCCT-3') in the CHRNB4 promoter is critical for β4 subunit gene expression in vivo; mutation of this element abolishes reporter gene expression at embryonic day 18.5 and drastically reduces it at postnatal day 30 in transgenic mice, and CA box mutation decreases interaction of transcription factor Sp1 with the β4 promoter.\",\n      \"method\": \"Transgenic mouse reporter assay, mutagenesis of promoter element, in vivo imaging of reporter expression, Sp1 binding assay\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo mutagenesis with reporter assay and transcription factor binding validation; multiple orthogonal methods\",\n      \"pmids\": [\"20696214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CHRNB4 promoter hypomethylation in lung tumors leads to overexpression of CHRNB4 transcript; treatment of H1299 cells with decitabine reduces methylation and elevates CHRNB4 mRNA, demonstrating epigenetic regulation. CHRNB4 knockdown in A549 and H1299 cells reduces proliferation and colony formation, indicating a functional role in tumorigenic potential.\",\n      \"method\": \"Bisulfite sequencing/methylation analysis, decitabine treatment, siRNA knockdown, proliferation and colony-formation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (methylation, pharmacologic demethylation, KD with two phenotypic readouts) in a single study\",\n      \"pmids\": [\"22945651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The human CHRNB4 gene (encoding the nAChR β4 subunit) was fully characterized including genomic structure and chromosomal mapping; mouse studies showed that loss of β4 subunit impairs bladder contraction in response to nicotine, and combined loss of β2 and β4 (but not single knockouts) produces severe autonomic phenotypes including megacystis and pupil dilation, establishing CHRNB4 as essential for autonomic ganglionic nicotinic receptor function.\",\n      \"method\": \"Gene characterization, mouse knockout phenotyping (bladder contraction assay, anatomical assessment), mutation analysis\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function mouse models with defined physiological readout; replicated with multiple genotypes\",\n      \"pmids\": [\"11450844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The Chrnb4-EGFP transgenic mouse line labels a sub-population of early retinal progenitors that becomes progressively restricted to mature cone photoreceptors during retina development, and native CHRNB4 protein is confirmed in EGFP-positive cone cells with a similar expression pattern in human retina.\",\n      \"method\": \"Transgenic reporter mouse characterization, immunohistochemistry, sub-retinal transplantation, live imaging\",\n      \"journal\": \"Molecular therapy : the journal of the American Society of Gene Therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with immunohistochemistry confirming native protein, tied to functional transplantation experiments\",\n      \"pmids\": [\"28143742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Conditional deletion of Dicer1 in Chrnb4-expressing cone photoreceptors (using Chrnb4-Cre) causes progressive cone degeneration with absent/short outer segments by 3 weeks of age, 50% cone loss by 4 months, and impaired photopic vision by ERG, demonstrating that CHRNB4-expressing cones require Dicer1 (and thus miRNA biogenesis) for survival and homeostasis.\",\n      \"method\": \"Conditional knockout mouse (Chrnb4-Cre; Dicer1 flox/flox), electroretinography, RNAseq, histology\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with functional (ERG) and molecular (RNAseq) readouts; validates Chrnb4-Cre as cone-specific driver\",\n      \"pmids\": [\"30783126\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CHRNB4 encodes the nicotinic acetylcholine receptor β4 subunit that forms heteropentameric nAChRs with α3 (and other) subunits; its expression is driven by an Sp1-dependent CA-box promoter element and is epigenetically regulated by promoter DNA methylation; rare missense variants alter receptor sensitivity to nicotine and acetylcholine, modulating nicotine dependence risk; in the autonomic nervous system β4-containing receptors are required for ganglionic cholinergic transmission (bladder contraction), and in the retina CHRNB4-expressing cone photoreceptors require Dicer1-dependent miRNA biogenesis for survival, while CHRNB4 overexpression (via promoter hypomethylation) promotes lung cancer cell proliferation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CHRNB4 encodes the β4 subunit of nicotinic acetylcholine receptors (nAChRs), which assembles with α3 and other α subunits into heteropentameric ligand-gated ion channels essential for autonomic ganglionic cholinergic transmission and modulation of nicotine sensitivity [PMID:11450844, PMID:24804708]. Transcription of CHRNB4 requires an Sp1-dependent CA-box promoter element, and its expression is regulated by promoter DNA methylation; hypomethylation-driven overexpression in lung cancer cells promotes proliferation and colony formation [PMID:20696214, PMID:22945651]. Rare missense variants in CHRNB4 alter agonist sensitivity of α3β4 receptors—increasing response to low nicotine concentrations—and are associated with reduced nicotine dependence risk [PMID:22042774, PMID:24804708]. Beyond the nervous system, CHRNB4 marks a cone photoreceptor lineage in the retina, where Dicer1-dependent miRNA biogenesis in CHRNB4-expressing cones is required for their survival and photopic visual function [PMID:28143742, PMID:30783126].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"The genomic structure of CHRNB4 was defined and knockout mouse studies established that the β4 subunit is required for nicotinic receptor-mediated autonomic ganglionic function, resolving whether β4 is redundant with other β subunits in vivo.\",\n      \"evidence\": \"Mouse knockout phenotyping (β4 single and β2/β4 double KO) with bladder contraction assays and anatomical assessment\",\n      \"pmids\": [\"11450844\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Autonomic phenotype of β4 single KO was mild; severe phenotypes required combined β2/β4 loss, leaving the degree of β4 vs β2 redundancy unresolved\",\n        \"No electrophysiological recordings from autonomic ganglia to define channel-level mechanism\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of the Sp1-dependent CA-box promoter element as essential for CHRNB4 transcription answered how tissue-appropriate expression of the β4 subunit gene is driven.\",\n      \"evidence\": \"Transgenic mouse reporter assay with CA-box mutagenesis and Sp1 binding analysis\",\n      \"pmids\": [\"20696214\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Other transcription factors or enhancers contributing to tissue-specific expression were not identified\",\n        \"The link between Sp1 binding and chromatin context was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Functional characterization of rare CHRNB4 missense variants demonstrated that specific amino acid changes increase receptor response to nicotine, providing a mechanistic basis for the protective association of these variants against nicotine dependence.\",\n      \"evidence\": \"In vitro co-expression of mutant β4 with α3 subunit, electrophysiology, and carrier-status genetic association\",\n      \"pmids\": [\"22042774\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Only two variants characterized in detail; broader variant landscape not functionally mapped\",\n        \"In vivo confirmation in animal models lacking\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstration that CHRNB4 is epigenetically silenced by promoter methylation and that its overexpression through hypomethylation contributes to lung cancer cell proliferation established a non-neuronal oncogenic role for this receptor subunit.\",\n      \"evidence\": \"Bisulfite sequencing, decitabine demethylation, siRNA knockdown with proliferation and colony-formation assays in A549/H1299 cells\",\n      \"pmids\": [\"22945651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Downstream signaling pathway linking β4 overexpression to proliferation was not defined\",\n        \"Whether the proliferative effect requires assembly into functional pentameric receptors is unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Systematic electrophysiological profiling of multiple CHRNB4 non-synonymous variants with α3 and α4 co-expression quantified how altered agonist EC50 and maximal response mediate genetic protection against smoking, refining the gain-of-function model for nicotine dependence risk.\",\n      \"evidence\": \"Voltage-clamp electrophysiology, cell-surface ELISA, qRT-PCR, gene-based association with functional weighting in HEK cells\",\n      \"pmids\": [\"24804708\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for variant-induced changes in agonist sensitivity not determined\",\n        \"Functional weighting approach not validated in independent cohorts\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovery that CHRNB4 marks a cone photoreceptor lineage in the retina expanded the known expression domain of β4 beyond the nervous system and provided a cone-specific genetic tool.\",\n      \"evidence\": \"Chrnb4-EGFP transgenic reporter mouse, immunohistochemistry confirming native β4 protein in cones, validated in human retina\",\n      \"pmids\": [\"28143742\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional role of β4 protein in cone photoreceptor physiology was not addressed\",\n        \"Whether β4 forms functional nAChR channels in cones is unknown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Conditional Dicer1 deletion in Chrnb4-Cre-expressing cones caused progressive cone degeneration and visual impairment, demonstrating that miRNA biogenesis is required for the survival of CHRNB4-expressing cone photoreceptors.\",\n      \"evidence\": \"Conditional knockout mouse (Chrnb4-Cre; Dicer1 flox/flox), ERG, RNAseq, histology\",\n      \"pmids\": [\"30783126\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific miRNAs responsible for cone survival were not identified\",\n        \"Whether β4 itself has a functional (non-Cre-driver) role in cone homeostasis remains untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The downstream signaling pathways through which β4-containing nAChRs promote lung cancer cell proliferation, the structural basis of variant-altered agonist sensitivity, and whether β4 forms functional ion channels in cone photoreceptors remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural data for α3β4 pentamer with disease-associated variants\",\n        \"Mechanism linking β4 overexpression to oncogenic signaling is undefined\",\n        \"Functional significance of β4 protein in retinal cones is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\n      \"α3β4 nicotinic acetylcholine receptor\"\n    ],\n    \"partners\": [\n      \"CHRNA3\",\n      \"CHRNA4\",\n      \"SP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}